7. Gay and bisexual men are how many times more likely to develop anal cancer than men who exclusively have sex with women? a. 10 times. b. 13 times. c. 15 times. d. 17 times. 8. HPV’s impact on women stems from its presence in 99.7% of all: a. Breast cancers. b. Cervical cancers. c. Endometrial cancers. d. Ovarian cancers. 9. Both the CDC and the American Academy of Pediatrics recommend that males receive the HPV vaccine starting at: a. Age 8. b. Age 11. c. Age 16. d. Age 21. 10. Which type of HPV is clearly linked to oral cancer? a. Type 1. b. Type 4. c. Type 8. d. Type 16. 11. Studies suggest that oral HPV is present in approximately what percentage of people in the U.S.? c. 12%. d. 19% 12. Common types of non-carcinogenic oral lesions associated with HPV include verruca vulgaris, condyloma acuminatum, and: a. Candidiasis. b. Kaposi’s sarcoma. c. Squamous papilloma. d. Squamous cell carcinoma. 13. In most cases, without treatment and depending on the virus type and the status of the individual’s immune system, the viral infection will clear to undetectable levels between: a. 3%. b. 7%. a. 3 to 6 months. b. 6 to 12 months. c. 12 to 24 months. d. 24 to 36 months. 14. Which of the following statements is true regarding the viral clearance of HPV? a. Low-risk HPV types clear more rapidly than high- risk types. b. Viral clearance typically happens between 1 to 3 months after infection. c. Clearance of naturally acquired virus confers immunity from future infection. d. Viral load has no effect on the length of time required for a virus to clear. 15. The United States Food and Drug Administration has approved HPV screening for: a. Cervical cancer. b. Oropharyngeal cancer. c. Anal cancer. d. Vaginal cancer. 16. Approximately what percentage of oropharyngeal squamous cell carcinomas are HPV-related?
17. Compared to HPV-negative head and neck cancer, HPV-positive cancers are typically: a. Larger in size. b. More responsive to therapy. c. More painful. d. More disfiguring. 18. Compared to other sexually transmitted diseases, the economic impact of HPV is: a. Felt solely by minority populations. b. The second most expensive. 19. The U.S. Food and Drug Administration (FDA) approved the HPV vaccine for females in 2006; the vaccine for boys and men became available in: a. The same year. b. 2007. c. 2009. d. 2011. 20. The FDA recommends that the HPV vaccine be administered to girls and boys: a. 9 to 10 years of age. b. 11 to 12 years of age. c. 13 to 14 years of age. d. 15 to 16 years of age. 21. The HPV vaccine is delivered as a series of 2-3 injections over a period of: a. 1 week. b. 6 weeks. c. 1 month. d. 6 months. 22. The duration of protection provided by the HPV vaccine is believed to be at least: c. Negligible. d. Unknown.
a. 2 years. b. 6 years. c. 10 years. d. 16 years
23. Talking to adult patients about the transmission, prevention, detection, treatment, progression, and risk of cancer from HPV should be introduced: a. When the patient schedules the appointment. b. As the oral exam is performed. c. Mid-treatment so a rapport can be established. d. At the conclusion of the treatment plan. 24. Data from the 2017 Youth Risk Behavior Surveillance System report revealed that the percentage of high school students who reported having had sexual intercourse for the first time before age 13 was: a. 1.9%. b. 3.4%. c. 5.6%. d. 7.9%. 25. Dental healthcare professionals play an important role in providing HPV-related prevention information to parents and adolescents because: a. More people in the U.S. have dental insurance than medical insurance. b. Adolescents are likely to see their dentist more often than other healthcare providers. c. People generally trust their dentists more than their primary physicians. d. Adolescents are always receptive to discussing sexual matters with adults.
a. 30-%-40%. b. 40%-50%. c. 60%-70%. d. 70%-80%.
Course Code : DCA04HP
Page 124
EliteLearning.com/Dental
Powered by FlippingBook